Cagrilintide CGL5 5mg*10vials

Cagrilintide CGL5 5mg*10 vials is a high-purity, research-grade dual-target amylin and calcitonin receptor agonist, and the standard core product of the Cagrilintide research peptide series. This standard 5mg dose features a highly stable molecular structure and excellent receptor binding selectivity, precisely developed for routine and moderate-intensity preclinical metabolic mechanism studies. Produced using multi-stage pharmaceutical-grade precision purification and professional vacuum lyophilization technology, the lyophilized powder maintains excellent molecular activity, good water solubility, and batch-to-batch stability. It effectively prevents molecular inactivation and efficacy loss during storage and reconstitution, fully meeting the stringent quality control standards for routine metabolic peptide studies in academic laboratories and pharmaceutical research institutions.

Product Function and Research Value

As a classic long-acting amylin analogue research tool, Cagrilintide CGL5 simultaneously activates the amylin and calcitonin receptor signaling pathways, thereby stabilizing and regulating systemic metabolic homeostasis. In laboratory applications, it is primarily used for mechanistic studies, covering the regulation of gastric emptying, moderate appetite suppression, regulation of daily calorie intake, adipocyte lipid metabolism, and the exploration of basal body weight homeostasis. Compared to high-dose CGL10, the 5mg standard specification offers a gentler, more controllable intervention intensity, making it more suitable for routine gradient experiments, short-term metabolic observations, and validation of basic physiological mechanisms. It exhibits a highly stable linear dose-response relationship with minimal experimental bias, generating highly reproducible and reliable research data. This specification is ideal for basic metabolic research, preliminary efficacy testing of peptide drugs, routine body composition regulation experiments, and low-dose synergistic effects studies of complex peptides.

Core Product Advantages

1. Dual-Target Synergistic Metabolic Regulation: Activates both amylin and calcitonin receptor pathways, achieving multi-dimensional metabolic regulation and providing a more comprehensive regulatory effect than traditional single-target metabolic research peptides.

2. Precise Standard Specification: Balanced medium-dose design with controllable intervention intensity, perfectly suited for basic laboratory experiments, dose gradient testing, and long-term routine metabolic modeling studies.

3. Excellent Solubility and Molecular Stability: High-quality lyophilized powder dissolves rapidly and completely in antibacterial water, resulting in uniform solution concentration and ensuring the purity of experimental variables, unaffected by impurities.

4. High-performance liquid chromatography (HPLC) detection, high purity, and good batch stability: Manufactured using standardized purification processes and strict quality inspection procedures, ensuring consistent biological activity across all batches, thereby guaranteeing the accuracy and reliability of experimental results.

5. Professional sterile laboratory packaging: 10 vials per box, individually sterile packaging, with complete COA certification, suitable for academic laboratory research, preclinical drug development trials, and global bulk wholesale procurement.

Cagrilintide CGL5 5mg*10 vials is a standard-dose dual-target amylin receptor agonist research peptide suitable for laboratory studies of basal metabolism and body composition. It features controlled metabolic intervention, stable molecular activity, and excellent solubility, supporting studies of appetite regulation, gastric emptying regulation, and basal lipid metabolism mechanisms. HPLC validated, with complete COA certification, available for global wholesale.